Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...
Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple ...
The WEA was founded in 1903 on the lofty principles of empowering working people to improve their own lives, participate more ...
New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple Infectious Disease Programs LIKMEZ® (ATI-1501): Building Commercial Momentum in the ...
LifeStance Health reports on the viral "6-7" trend among kids, highlighting its role in fostering connection and emotional ...
27 Department ofEpidemiology and Preventive Medicine, University of Regensburg, Germany 28 Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia Faculty of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback